Morgan Stanley’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-62,229
| Closed | -$44.6K | – | 8039 |
|
|
2024
Q1 | $44.6K | Sell |
62,229
-398,803
| -87% | -$286K | ﹤0.01% | 6258 |
|
|
2023
Q4 | $392K | Buy |
461,032
+424,561
| +1,164% | +$361K | ﹤0.01% | 5712 |
|
|
2023
Q3 | $50K | Sell |
36,471
-11,830
| -24% | -$16.2K | ﹤0.01% | 6170 |
|
|
2023
Q2 | $122K | Buy |
48,301
+34,825
| +258% | +$87.8K | ﹤0.01% | 5859 |
|
|
2023
Q1 | $30.6K | Buy |
13,476
+8,950
| +198% | +$20.3K | ﹤0.01% | 6466 |
|
|
2022
Q4 | $6.34K | Sell |
4,526
-3,907
| -46% | -$5.47K | ﹤0.01% | 7089 |
|
|
2022
Q3 | $16K | Sell |
8,433
-2,945
| -26% | -$5.59K | ﹤0.01% | 6901 |
|
|
2022
Q2 | $18K | Buy |
11,378
+3,561
| +46% | +$5.63K | ﹤0.01% | 7033 |
|
|
2022
Q1 | $34K | Sell |
7,817
-3,385
| -30% | -$14.7K | ﹤0.01% | 6891 |
|
|
2021
Q4 | $63K | Buy |
+11,202
| New | +$63K | ﹤0.01% | 6700 |
|